Professor, Neurology-Massachusetts General Hospital, Harvard Medical School
Neurology
Dr. Jonathan Rosand, MD
|
|
Give Review
Doctor Jonathan Rosand, MD practices Neurology. He went to Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a one of the best medicals schools. Columbia University College of Physicians & Surgeons is ranked 8 in research and 52 in primary care medicine Jonathan Rosand is a published doctor and has 68 publications published. The lastest was: 'Blood Pressure Control and Recurrence of Intracerebral Hemorrhage--Reply.' Jonathan Rosand accepts Medicare.
Publications
- Predicting IntraCerebral Hemorrhage Growth With the Spot Sign: The Effect of Onset-to-Scan Time.
- Hypernatremia at Hospital Discharge and Out of Hospital Mortality Following Primary IntraCerebral Hemorrhage.
- Blood Pressure Control and Recurrence of IntraCerebral Hemorrhage--Reply.
- Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
- White matter hyperintensity patterns in Cerebral amyloid angiopathy and hypertensive arteriopathy.
- Heritability of young- and old-onset ischaemic Stroke.
- COMT Val (158) Met polymorphism is associated with nonverbal cognition following mild traumatic Brain injury.
- Integrative Mouse and Human Studies Implicate ANGPT1 and ZBTB7C as Susceptibility Genes to Ischemic Injury.
- Measurement of perihematomal edema in intraCerebral hemorrhage.
- Metabolic determinants of white matter hyperintensity burden in patients with ischemic Stroke.
- Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic Stroke onset.
- Targeting secondary injury in intraCerebral haemorrhage--perihaematomal oedema.
- Genetic architecture of white matter hyperintensities differs in hypertensive and nonhypertensive ischemic Stroke.
- Recommendations from the international Stroke genetics consortium, part 2: biological sample collection and storage.
- Recommendations from the international Stroke genetics consortium, part 1: standardized phenotypic data collection.
- Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network.
- Structural network alterations and neurological dysfunction in Cerebral amyloid angiopathy.
- Interrelationship of superficial siderosis and microbleeds in Cerebral amyloid angiopathy.
- Aspirin should be discontinued after lobar intraCerebral hemorrhage.
- Infection After IntraCerebral Hemorrhage: Risk Factors and Association With Outcomes in the Ethnic/Racial Variations of IntraCerebral Hemorrhage Study.
- Agreement between TOAST and CCS ischemic Stroke classification: The NINDS SiGN Study.
- Targeting the Immune System in IntraCerebral Hemorrhage.
- Microinfarct disruption of white matter structure: A longitudinal diffusion tensor analysis.
- Risk factors for computed tomography angiography spot sign in deep and lobar intraCerebral hemorrhage are shared.
- Incidence of Symptomatic Hemorrhage in Patients With Lobar Microbleeds.
- Assessment of satisfaction with care among family members of survivors in a neuroscience intensive care unit.
- Current concepts and clinical applications of Stroke genetics.
- Meta-analysis of Genome-wide Association Studies Identifies 1q22 as a Susceptibility Locus for IntraCerebral Hemorrhage.
- Genetic variation of oxidative phosphorylation genes in stroke and Alzheimer's Disease.
- Anxiety and depression symptoms among families of adult intensive care unit survivors immediately following brief length of stay.
- Accuracy of imputation to infer unobserved APOE epsilon alleles in genome-wide genotyping data.
- Genome-wide linkage approach yields novel early onset myocardial infarction locus in East asians.
- Predicting Hematoma Expansion After Primary IntraCerebral Hemorrhage.
- Interaction between genetic variants and exposure to Hurricane Katrina on post-traumatic stress and post-traumatic growth: A prospective analysis of low income adults.
- The Ethnic/Racial Variations of IntraCerebral Hemorrhage (ERICH) Study Protocol.
- Stroke Genetics Network (SiGN) Study: Design and Rationale for a Genome-Wide Association Study of Ischemic Stroke Subtypes.
- Prospective Validation of the Computed Tomographic Angiography Spot Sign Score for IntraCerebral Hemorrhage.
- Predictors of Hematoma Volume in Deep and Lobar Supratentorial IntraCerebral Hemorrhage.
- Acute respiratory distress syndrome after spontaneous intraCerebral hemorrhage*.
- Warfarin and Statins are Associated with Hematoma Volume in Primary Infratentorial IntraCerebral Hemorrhage.
- Computed Tomography Angiography Spot Sign Does Not Predict Case Fatality in Aneurysmal Subarachnoid Hemorrhage With Intraparenchymal Extension.
- DEVELOPMENTAL TIMING OF CHILD MALTREATMENT AND SYMPTOMS OF DEPRESSION AND SUICIDAL IDEATION IN YOUNG ADULTHOOD: RESULTS FROM THE NATIONAL LONGITUDINAL STUDY OF ADOLESC...
- Authors' Reply: Confounding by Indication in Retrospective Studies of IntraCerebral Hemorrhage: Antiepileptic Treatment and Mortality.
- Burden of blood pressure-related alleles is associated with larger hematoma volume and worse outcome in intraCerebral hemorrhage.
- Common Variants Within Oxidative Phosphorylation Genes Influence Risk of Ischemic Stroke and IntraCerebral Hemorrhage.
- Confounding by indication in retrospective studies of intraCerebral hemorrhage: antiepileptic treatment and mortality.
- Risk of intracranial Hemorrhage with protease-activated receptor-1 antagonists.
- Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study.
- Characteristic distributions of intraCerebral hemorrhage-associated diffusion-weighted lesions.
- Clinical Applications of the Computed Tomography Angiography Spot Sign in Acute IntraCerebral Hemorrhage: A Review.
- CTA Spot Sign Predicts Hematoma Expansion in Patients with Delayed Presentation After IntraCerebral Hemorrhage.
- Apolipoprotein E Genotype Is Associated With CT Angiography Spot Sign in Lobar IntraCerebral Hemorrhage.
- SCORE-IT: the Spot Sign score in restricting ICH growth-an Atach-II ancillary study.
- Predicting sites of new hemorrhage with amyloid imaging in Cerebral amyloid angiopathy.
- Functional magnetic resonance imaging detection of vascular reactivity in Cerebral amyloid angiopathy.
- A genome-wide scan for common variants affecting the rate of age-related cognitive decline.
- Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
- Apolipoprotein E Genotype Predicts Hematoma Expansion in Lobar IntraCerebral Hemorrhage.
- Process Improvement Methods Increase the Efficiency, Accuracy, and Utility of a Neurocritical Care Research Repository.
- Should we test for CYP2C9 before initiating anticoagulant therapy in patients with atrial fibrillation?
- Anemia and hematoma volume in acute intraCerebral hemorrhage.
- MR imaging detection of Cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength.
- Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation.
- Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B.
- Impaired visual evoked flow velocity response in Cerebral amyloid angiopathy.
- Dopamine Genetic Risk Score Predicts Depressive Symptoms in Healthy Adults and Adults with Depression.
- Genetic determinants of depression: recent findings and future directions.
Schools
Columbia University College Of Physicians and Surgeons
Massachusetts General Hospital
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Anterior Horn Disease
- Brain Aneurysm
- Carotid Artery Disease
- Cerebral Artery Thrombosis
- View All
Doctors Specialties
- Vascular Neurology
- Neurology
Accepted Insurances
Education
-
Massachusetts General Hospital -
Columbia University College of Physicians & Surgeons
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1194715524 | |
| NPPES Provider LastName | ROSAND | |
| NPPES Provider FirstName | JONATHAN | |
| NPPES Provider ZIPCode | 021143117 | |
| NPPES Provider State | MA | |
| Specialty Description | Neurology | |
| Total Claim Count | 11.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194715524 |
| Last Name Of The Provider | ROSAND |
| First Name Of The Provider | JONATHAN |
| View All |
Similar Doctors
|
|
Dr. Michael A. Schwarzschild, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Martha R. Herbert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine T. Dawson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bashar Zleik, MD |
|
|
Dr. Steven A. Greenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mingming Ning, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Louis R. Caplan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Aleksandra Pikula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven M. Tanabe, MD
This Doctor is OpenDoctor Recommended.
|